Brief: Eton Pharmaceuticals Under Terms Of Deal Co Will Pay Seller $2.2 Million For Acquisition & Could Pay Up To $2 Million In Additional Commercial Milestones
March 22 (Reuters) - Eton Pharmaceuticals Inc ETON.O :
* ETON PHARMACEUTICALS: UNDER TERMS OF DEAL CO WILL PAY
SELLER
$2.2 MILLION FOR ACQUISITION & COULD PAY UP TO $2 MILLION IN
ADDITIONAL COMMERCIAL MILESTONES
Source text for Eikon: ID:n0001437749-24-008919
Further company coverage: ETON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer